Feb 24, 2015 7:00am EST NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014
Feb 04, 2015 6:00am EST NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015
Jan 22, 2015 5:55pm EST NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014
Dec 16, 2014 7:00am EST NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program
